Citigroup
TARA icon

Citigroup’s Protara Therapeutics TARA Stock Holding History

Citigroup’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$92.2K Buy
24,145
+9,669
+67% +$46K ﹤0.01% 4730
2026
Q1 		$75.4K Sell
14,476
-224
-2% -$1.33K ﹤0.01% 4379
2025
Q4 		$78.4K Buy
14,700
+14,322
+3,789% +$79.6K ﹤0.01% 4422
2025
Q3 		$1.64K Sell
378
-10,460
-97% -$33.9K ﹤0.01% 5532
2025
Q2 		$32.8K Buy
10,838
+7,199
+198% +$24.8K ﹤0.01% 4947
2025
Q1 		$15.5K Sell
3,639
-9,306
-72% -$41.6K ﹤0.01% 5132
2024
Q4 		$68.3K Buy
+12,945
New +$41.8K ﹤0.01% 4989
2021
Q3 		– Sell
-15
Closed – – 6283
2021
Q2 		$0 Sell
15
-242
-94% -$2.74K ﹤0.01% 6391
2021
Q1 		$4K Sell
257
-457
-64% -$8.47K ﹤0.01% 5954
2020
Q4 		$17K Buy
714
+617
+636% +$13.3K ﹤0.01% 6747
2020
Q3 		$2K Sell
97
-161
-62% -$3.73K ﹤0.01% 7318
2020
Q2 		$8K Sell
258
-1,555
-86% -$48.1K ﹤0.01% 7146
2020
Q1 		$43K Buy
+1,813
New +$52.8K ﹤0.01% 6115
2016
Q4 		– Sell
-15
Closed -$6K – 7328
2016
Q3 		$6K Hold
15
– – ﹤0.01% 6728
2016
Q2 		$5K Sell
15
-134
-90% -$40.1K ﹤0.01% 6788
2016
Q1 		$46K Buy
149
+91
+157% +$29.3K ﹤0.01% 6154
2015
Q4 		$36K Buy
+58
New +$34K ﹤0.01% 6164
2015
Q3 		– Sell
-3
Closed -$1.86K – 7701
2015
Q2 		$2K Buy
+3
New +$1.86K ﹤0.01% 7153

Other funds holding TARA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Citigroup's TARA Position: Q2 2026 in Review

Citigroup increased its Protara Therapeutics (TARA) stake by 67% in Q2 2026, buying an estimated $46K and bringing the position to 24,145 shares worth $92.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4730.

Citigroup first reported a position in TARA in Q2 2015 and has held it in 18 quarters since. 120 funds tracked by Wall St. Rank hold TARA as of Q2 2026.

  • Citigroup held 24,145 shares of Protara Therapeutics worth $92.2K as of Q2 2026.
  • Citigroup bought 9,669 Protara Therapeutics shares in Q2 2026, an estimated $46K.
  • Protara Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #4730 holding.
  • Citigroup first reported a position in Protara Therapeutics in Q2 2015 and has held it in 18 quarters since.
  • 120 funds tracked by Wall St. Rank held Protara Therapeutics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.